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Background: The blaZ gene encoding penicillin resistance can be located either chromosomally or on plasmids.
The aim of this study was to investigate the genetic relationships and to determine the location of the blaZ gene in
S. aureus isolated in bovine mastitis in Finland and Sweden.
Methods: Seventy-eight β-lactamase positive S. aureus isolates from bovine mastitis (34 from Finland and 44 from
Sweden) were included in the study. The localization of blaZ gene was determined by Southern blotting. The blaZ
genes of the isolates were sequenced and the sequences were translated to beta-lactamase proteins and further
grouped as different protein signatures. The isolates and, as control, 33 Swedish and 36 Finnish beta-lactamase
negative isolates were typed with pulsed-field gel electrophoresis (PFGE).
Results: In 26 out of 34 Finnish isolates (76.5%) and in 25 out of 44 Swedish isolates (56.8%) the blaZ gene was
localized on a plasmid. Six different protein signatures were found. One signature was found only in four Swedish
isolates, but all other signatures were found both in Finnish and Swedish isolates. The PFGE results revealed a
diversity of S. aureus clones. The protein signatures were not clearly associated with certain pulsotypes.
Conclusions: The plasmid location of the blaZ gene was not statistically significantly more common in Finland
than in Sweden, and hence does not explain the higher proportion of penicillin-resistant isolates of S. aureus
causing bovine mastitis in Finland compared to Sweden.
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Staphylococcal mastitis is a main problem of the
dairy industry in many countries [1]. For mastitis with
penicillin-susceptible S. aureus, benzylpenicillin is con-
sidered a first-line antibiotic due to its advantages
compared with beta-lactamase stable penicillin [2]. Un-
fortunately, resistance to benzylpenicillin is common
among mastitis-causing staphylococci, but varies largely
between countries [3]. Low prevalences of penicillin-
resistant S. aureus have been reported in Sweden (3.7 to
7.1%) and Norway (5.0 to 11.4%) [3-6] and in Canada
(8.7%) [7]. High prevalences of penicillin-resistance have
been reported for example in Estonia (61.4%). In
England (36 to 46%) and in Korea (38.6 to 78.8%) [3,8,9].
In a prevalence survey in Finland, 52.1% of S. aureus iso-
lates were penicillin-resistant [10]. In two other studies* Correspondence: suvi.taponen@helsinki.fi
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reproduction in any medium, provided the orthe level of resistance was lower, 22.9% and 25.0%
[11,12]. It is, however, peculiar, why penicillin-resistance
is clearly more common in Finland than in the neigh-
bouring Nordic countries with similar conditions for
milk production. One explanation could be the more
common plasmid location of the blaZ gene and
plasmid-mediated spread of penicillin-resistance.
Resistance to benzylpenicillin is mainly caused by the
blaZ gene encoding production of beta-lactamases,
which hydrolytically destroy beta-lactams [13]. The blaZ
gene can be located chromosomally or on plasmids [14].
This type of penicillin resistance in S. aureus may thus
emerge via two mechanisms: spread of resistant clones
or through horizontal dissemination of mobile elements
containing the blaZ gene [15,16]. Location of the resist-
ance determinants on transferable elements generally
promotes efficient spread [16]. In Denmark the blaZ
gene of penicillin resistant S. aureus isolates has been
predominately located chromosomally [17]. Diversity ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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etic analysis [18,19] and be compared with published
blaZ sequences, to find out possible relatedness.
The aim of this study was to investigate the location
and diversity of the blaZ gene in S. aureus isolated in
bovine mastitis in Finland and Sweden. In addition, the
genetic relationships of S. aureus isolates were investi-
gated. Our hypothesis was that location of the resistance
gene on a plasmid would be associated with a higher
prevalence of resistance. In addition, we investigated the
diversity of blaZ sequences and compared the amino
acid sequences of the beta-lactamase protein according
to Olsen et al. [18].
Methods
Bacterial isolates
A total of 78 beta-lactamase positive S. aureus isolates
from bovine mastitis (34 isolates from Finland and 44
isolates from Sweden) from previous surveys were
included in the study. Out of the 34 isolates from
Finland, 15 were collected in 2001 from subclinical mas-
titis [10] and 19 were collected in 2005 from clinical
mastitis [12]. Out of the 44 Swedish isolates, 18, 12 and
14 isolates were from 2001, 2002/2003 and 2005, re-
spectively. The isolates from 2001 and 2005 were from
subclinical/chronic mastitis and were collected from
diagnostic submissions to the Swedish National Veterin-
ary Institute. The isolates from 2002/2003 were collected
in a specific study on acute clinical mastitis [5].
Sixty-nine beta-lactamase negative isolates from both
countries (36 isolates from Finland and 33 isolates from
Sweden) were included in the pulsed-field gel electro-
phoresis (PFGE) analyses for comparison. Fourteen
Finnish isolates were from 2001 and 22 from 2005. Out
of the 33 Swedish isolates; 18 isolates were from 2001
and 15 from 2002/2003. The 36 Finnish and 33 Swedish
beta-lactamase negative isolates originated from the
same surveys described above [5,10,12].
The reference strain S. aureus ATCC 29213 was used
for both nuc and blaZ PCR assays as a positive control
and also for the probe preparation for Southern blotting.
A beta-lactamase-producing S. aureus strain SV 41 was
used in Southern blotting as the control of plasmid lo-
calisation of the blaZ gene [18].
Confirmation of the isolates and PCR detection of the
blaZ gene
Species confirmation was performed using PCR amplifi-
cation of the thermonuclease (nuc) gene with the pri-
mers; P-1: 50 GCG ATT GAT GGT GAT ACG GTT 30;
P-2: 50 AGC CAA GCC TTG ACG AAC TAA AGC 30
as described previously [20]. After the confirmation of
presence of the nuc gene, all the isolates were further
examined for the blaZ gene by using primers (blaZ 1: 50TTA AAG TCT TAC CGA AAG CAG 30; blaZ 2: 50
TAA GAG ATT TGC CTA TGC TT- 30) designed by
Olsen et al. [18]. The PCR-amplified products were
separated by electrophoresis in a 1.5% agarose gel in lx
TBE buffer (pH 8.3; 0.09 M Tris, 0.09 M boric acid,
2.0 mM EDTA) and stained with ethidium bromide
(0.5ug/ml final concentration), visualized in UV-light
and image analysed on AlphaImager HP Digital Imaging
System, Model DE-500 (Alpha Innotech Corporation,
San Leandro, CA, USA).
Location of the blaZ gene in penicillin-resistant strains
The beta-lactamase positive isolates were included in
Southern blotting analysis for the detection of the loca-
tion of the blaZ gene. The bacteria were cultivated in
10 ml of Trypticase soy broth (TSB), supplemented with
10% yeast extract and benzylpenicillin at a final concen-
tration of 8 μg/ml [17].
Purification and digestion of chromosomal DNA and
plasmid DNA
DNA was purified using the Easy-DNA™ Kit for genomic
DNA isolation (Invitrogen Life Technologies, Carlsbad,
CA, USA) according to the manual. For lysis of bacterial
cells, 10 μl of lysostaphin (10 mg/mL) and 7, 5 μl of
lysozyme (20 mg/mL) were added and the suspensions
incubated at 37°C for 45 min. The E.Z.N.A.™ Plasmid
Miniprep Kit (Omega Bio-Tek. Inc., GA, USA) was used
for the purification of plasmid DNA. Purified chromo-
somal and plasmid DNA were digested with one unit of
EcoRI (Roche Diagnostic, Mannheim, Germany) and
EcoRV (Roche Diagnostic) for 2 h and run on a 0.8%
Tris–borate EDTA agarose gel. A Digoxigenin (DIG)-
labelled DNA Molecular Weight Marker II (Roche Diag-
nostic) served to determine the size of the digested
chromosomal fragments [18].
Southern blotting
A probe (377 bp) for the blaZ gene was prepared by
PCR amplification on the S. aureus ATCC 29213 using
the primers P1 and P2. Probe DNA was purified using
Easy DNA Kit (Invitrogen, K1800-01) and labelled with
digoxigenin-11-dUTP using DIG PCR Probe Synthesis
Kit (Roche Diagnostic). DNA bands from chromosomal
and plasmid digests were transferred from agarose gels
onto Nylon membranes (Roche Diagnostic) by capillary
transfer following depurination in 250 mM HCl, de-
naturation in 0.5 M NaOH, 1.5 M NaCl and
neutralization in 0.5 M Tris–HCl, 1.5 M NaCl steps, as
previously described [21]. Blots were prehybridised for
2 h at 42°C in prehybridisation solution (DIG Easy Hyb;
Roche Applied Science). Denatured probe was added
and hybridised to membranes for 12 h at 42°C in a
hybridization oven. Membranes were then washed twice
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Citrate (SSC) buffer containing 0.1% Sodium Dodecyl
Sulfate (SDS), and then twice for 15 min at 65°C in 0.5 ×
SSC–0.1% SDS. Chromogenic detection method was
used for the visualization of the probes on the blot.PFGE analysis
Both beta-lactamase positive and negative isolates (to-
tally 147 isolates) were examined by PFGE as previously
described by Salmenlinna et al. [22]. Briefly, S. aureus
colonies from overnight cultures were incorporated into
low melting agarose (2%) plugs. The DNA purification
protocol included lysostaphin and proteinase K treat-
ment, followed by washing steps with phenylmethylsul-
fonyl fluoride and TE buffer (10 mM Tris and 1 mM
EDTA, pH 8.0). Genomic DNA was digested using SmaI
at room temperature, overnight. PFGE was performed
by clamped homogeneous electric field (CHEF) electro-
phoresis with a CHEF-DR III System (Bio-Rad Labora-
tories, CA, USA) in a 1% (w/v) SeaKem agarose gel
(FMC BioProducts, USA) at 6 V/cm by two phases:
phase 1 for 10 h, with the initial and final switching
times of 5 s to 15 s; and phase 2 for 13 h, with 15 s to
60 s, respectively. A Lambda Ladder PFG marker (New
England BioLabs, USA) was used as the molecular
weight standard. Fragments ranging from 50 to 800 kb
were included in the analysis. Gels were analysed using
BioNumerics v. 4.61 software (Applied Maths, Kortrijk,
Belgium), and cluster analysis was performed by
Unweighted Pair Group Method with Arithmetic Mean
(UPGMA) based on the Dice similarity coefficient, with
optimization and position tolerance set at 1.5%. Finger-
prints with more than three band shifts were interpreted
as being of a different pulsotype and thus the strains
genetically unrelated.Sequencing of the blaZ gene
The blaZ genes of the beta-lactamase positive isolates
were sequenced in the Institute of Biotechnology,
Helsinki. The primers used for sequencing of plasmid
located blaZ were 486: GTTGCGAACTCTTGAATAGG
and 531: AATTCCTTCATTACACTCTTGG [18]. The
primers used for sequencing of chromosomally located
blaZ were 1 F: TACAACTGTAATATCGGAGGG and
1R: CATTACACTCTTGGCGGTTTC [19]. The gene
sequences were translated to amino acid sequences
using Transeq Nucleotide to Protein Conversion
(European Bioinformatics Institute). The blaZ nucleotide
sequences and the corresponding beta-lactamase amino
acid sequences were compared with published
sequences, retrieved from the GenBank, using BioNu-
merics24.61 software (Applied Maths). The amino acid
sequences were grouped into protein signatures (threeor less deviations in amino acid composition) according
to Olsen et al. [18].
Statistical methods
Frequencies of plasmid versus chromosomal location of
blaZ genes in isolates from Sweden and Finland, and in
isolates from clinical versus subclinical mastitis were
compared using Pearson’s chi-square test.
Results
Confirmation of the isolates
All 147 isolates included in the study were S. aureus, as
they showed amplification products at approximately
270 bp for nuc gene. All the 78 beta-lactamase positive
isolates had the blaZ gene confirmed by showing bands
at 377 bp.
Location of the blaZ gene in penicillin-resistant strains
Based on the Southern blotting, the blaZ gene was
located on the chromosome in 27 isolates and on plas-
mids in 51 isolates. In 26 of the 34 beta-lactamase
positive Finnish isolates (76%) and in 25 of the 44 beta-
lactamase positive Swedish isolates (56.8%), the blaZ
gene was located on a plasmid. The difference of the
blaZ gene location between the Finnish and Swedish iso-
lates was not statistically significant (p = 0.094).
Of the 27 isolates with chromosomally located blaZ,
12 (44.4%) were from clinical mastitis and 15 (55.6%)
from subclinical mastitis. Of the 51 isolates with
plasmid-located blaZ, 19 (37.3%) were from clinical
and 32 (62.7%) from subclinical mastitis. The location
of blaZ did not significantly differ between isolates
from different type of mastitis (clinical vs. subclinical)
(p = 0.629).
PFGE analysis
The 147 S. aureus isolates showed 81 different pulso-
types. Twenty-seven, 18 and 16 isolates belonged to
three dominating pulsotypes; the other pulsotypes
included mainly one or few isolates. The most common
pulsotype (28 isolates, 18 Finnish and 10 Swedish)
included only beta-lactamase negative isolates. The pul-
sotype with 18 isolates (3 Finnish, 15 Swedish) included
16 isolates carrying the blaZ gene on a plasmid and two
beta-lactamase negative isolates. The pulsotype with 16
isolates (7 Finnish and 9 Swedish) included 15 beta-
lactamase negative isolates and one isolate carrying the
blaZ gene on the chromosome. Most of the pulsotypes
included few either beta-lactamase positive or negative
isolates.
Sequencing of the blaZ gene
The blaZ gene of 71 isolates (47 plasmid and 24 chro-
mosomally located) of the total of 78 blaZ possessing
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mid-located and 6 chromosomally located blaZ regions
were successfully amplified and sequenced using the pri-
mer pair 486–531. The length of the obtained sequences
were 797 bp. Amplification of the chromosomally
located blaZ regions of 18 isolates failed with these pri-
mers but succeeded using the primer pair 1F-1R, and
sequences of 833 bp were obtained. In the further ana-
lysis, the region from 1 to 797 bp of the total blaZ gene
of 846 bp of all 72 isolates was used. When the
sequences were translated to proteins, amino acid
sequences of 265 amino acids of the total length of 281
amino acids of the beta-lactamase protein were
obtained.
Eighteen different amino acid sequences were
obtained. Six different protein signatures, the signatures
1, 2, 3, 5, 6, and a new signature 2/5, which had similar-
ities with the signatures 2 and 5, were found (Table 1).
The most common signature type was the signature 3,
including 24 plasmid and one chromosome located blaZ.
The signature 6 included only chromosomally located
blaZ (n = 17) and the signature 2 mainly plasmid located
blaZ (15 plasmid, 1 chromosome). The protein signature
of 7 isolates, including five chromosomally and two plas-
mid located blaZ, fell between the protein signatures 2
and 5, having >3 amino acid deviations from both. The
protein signature of this group was similar (0 to 1 devia-
tions) to the protein signature of Enterococcus faecalis
with GenBank accession number U43087 [23], reported
to belong to the protein signature 5 [18,19], but different
(>3 deviations) from the other protein signature 5 refer-
ences with accession numbers M25257, AY373761,
AJ302698, and DQ919081.
The four isolates with the signature type 1 had an al-
most identical pulsotype, as had also the seven isolates
with the signature type 2/5. The 25 isolates with the sig-
nature type 3 were divided into two groups of similar
pulsotypes. The 16 isolates with the signature type 2 hadTable 1 Beta-lactamase protein signatures of the blaZ genes
isolates in bovine mastitis in Finland and Sweden
Protein
signature
Finland Sweden
Chromosome Plasmid Chromosome Plasmid Total
1 4 4
2 1 13 2 16
3 10 1 14 25
5 1 1 2
6 4 13 17
2/5 3 1 2 1 7
Total 8 25 16 22 71
Fingerprints of the pulsed field gel electrophoresis (PFGE) with more than three ban
genetically unrelated.rather similar pulsotypes but the 17 isolates with the sig-
nature type 6 had 11 different pulsotypes (Table 1).
We compared the beta-lactamase protein sequences of
our isolates with the sequences submitted to the Gen-
Bank having a known beta-lactamase serotype or protein
signature. The type B beta-lactamase corresponded to
the protein signature 6, only found from isolates carry-
ing the blaZ gene on the chromosome. The beta-
lactamase type A corresponded to the protein signature
1, and the beta-lactamase type D to the protein signature
5, but representatives of beta-lactamase type C corre-
sponded both to the protein signatures 2 and 3.
Discussion
In most (76%) of the Finnish S. aureus isolates and in
over half (57%) of the Swedish isolates blaZ gene was
residing on a plasmid. The high proportion of
penicillin-resistant S. aureus in Finland [10,12] could
have been explained by plasmid-mediated resistance.
However, nearly half of the Swedish isolates also had
the gene on a plasmid but prevalence of penicillin
resistant S. aureus has been low in Sweden [5,6]. Pos-
session of the blaZ gene was partly linked to pulsotype,
which may indicate a clonal spread of resistance. Under
the selection pressure of antibiotic use, resistant popu-
lations of bacteria have advantage over susceptible ones
and can become dominant. If possession of a resistance
gene results in a fitness cost, resistant clones would
disappear after cessation of antibiotic use. However,
regarding blaZ-positive S. aureus, no evidence of a
possible fitness cost is available as shown for some
Gram-negative bacteria with other beta-lactamase genes
[24]. It seems that other factors than location of the
blaZ gene explain different prevalence of penicillin re-
sistance among mastitis causing S. aureus in Sweden
and Finland.
In spite of introduction of large scale mastitis control
programs, S. aureus has remained a major mastitislocated chromosomally or on a plasmid in S. aureus
Pulsotypes
2 different pulsotypes
8 different pulsotypes
Two clusters of >64% similarity, with 8 and 4 different pulsotypes
2 pulsotypes with 78% similarity
9 different pulsotypes
A cluster of 4 pulsotypes with 81% similarity and 1 pulsotype with 61%
similarity within the cluster
d shifts were interpreted as being of a different pulsotype and thus the strains
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can persist for long periods in the mammary gland and
needs to be treated with antimicrobials [25]. In human
medicine, benzylpenicillin has lost its value as a thera-
peutic agent for treatment of S. aureus infections, be-
cause almost 100% of the isolates have been resistant for
decades [26]. In isolates of human origin, the blaZ gene
has been reported to be located predominantly on a
plasmid [26]. For treatment of bovine staphylococcal
mastitis, benzylpenicillin can still be regarded as a first-
line antibiotic [2,27].
Many countries regularly monitor resistance of animal
pathogens, including S. aureus isolates in bovine mas-
titis, by national monitoring programs. Based on the
reports of these programs and other investigations, peni-
cillin resistance of S. aureus is the most common form
of antimicrobial resistance among mastitis causing bac-
teria [3,8]. In Finland, a nation-wide survey carried out
in 2001 showed that the proportion of penicillin-
resistant S. aureus isolates was 52% in subclinical mas-
titis [10]. In a more recent study on isolates from clinical
mastitis, the proportion of resistance was only 25% [12].
The decreasing trend in penicillin-resistance of S. aureus
could be due to mastitis control measures such as cul-
ling of cows infected with resistant isolates, but also due
to the more prudent use of antibiotics [28]. However,
the data are not fully comparable as the first originate
from subclinical and the more recent from clinical mas-
titis. The differences in prevalence of penicillin-resistant
S. aureus isolated in mastitis observed between countries
may be explained by different management options to
control S. aureus mastitis but possibly also by different
use patterns of antimicrobials for mastitis treatment
[15]. In Norway and Sweden, use of antimicrobials has
been very restricted and benzylpenicillin has practically
been the only antimicrobial used to treat mastitis over
decades [27,29]. This indirect evidence may indicate that
use of benzylpenicillin does not efficiently select for
penicillin-resistance among mastitis causing S. aureus.
Yet, systemic administration of penicillin or intramam-
mary administration of dry cow penicillin-novobiocin
combination were associated with penicillin resistance in
Canadian dairy herds [7]. Similar results were reported
also by Pol and Ruegg [30]. Together with restricted
antimicrobial policy, strict culling of cows with mastitis
caused by penicillin-resistant S. aureus has been advised
for long in Sweden and in Norway. In Finland a wider
selection of intramammary products containing broad-
spectrum antimicrobials and combinations of different
substances were earlier used [31]. In most countries,
consumption figures of antimicrobials for different ani-
mal species are not available or not detailed enough, and
no conclusions can be made on the associations between
antimicrobial use and resistance.The beta-lactamases of S. aureus have been classified
immunologically by the serotype into four classes, types
A-D [26]. The gene variant encoding the type B beta-
lactamase is located on the chromosome whereas the
gene variants encoding the types A, C, and D beta-
lactamases are usually located on a plasmid [26]. These
four beta-lactamase types correspond with the blaZ pro-
tein sequence signatures established by Olsen et al. [18],
who reported 11 protein signature types for the blaZ
sequences from staphylococci of different origin. Malik
et al. [19] used the same protein signature classification
and detected four known protein signature types and
one new type from isolates from dogs and cats. We
found five of these protein signatures, the signatures 1,
2, 3, 5 and 6, and a new signature, which had similarities
both with the signatures 2 and 5 and was named 2/5.
The majority of our isolates with the blaZ gene in the
chromosome were of the protein signature type 6, which
clustered with the beta-lactamase protein sequences
from the GenBank having the beta-lactamase serotype B.
The protein signature 6 was detected only in isolates
with chromosomal location of the blaZ gene. This is in
concordance with earlier studies [26]. The new protein
signature type 2/5 was found in seven isolates (4 Finnish
and 3 Swedish), of which five carried the blaZ gene on
the chromosome. The pulsotypes of these isolates were
very similar, indicating clonal spread. The protein signa-
ture 1 corresponded with the beta-lactamase type A, and
the protein signature 5 with the beta-lactamase type D.
The protein signatures 2 and 3 corresponded with the
beta-lactamase type C. With two exceptions, the protein
signatures 1, 2, 3 and 5 were found in plasmid located
blaZ,which is in agreement with other studies [18,26].
Certain genotypes of mastitis causing S. aureus can be-
come dominant in the dairy herds [25]. In the three
most common pulsotypes here blaZ-negative isolates
were over-represented, indicating that penicillin-
resistance was partly related to pulsotype. An association
between certain pulsotypes and penicillin susceptibility
has also been shown previously [32,33]. Penicillin-
resistance may be linked to other virulence factors of
S. aureus, which may facilitate the spread of resistant
clones [33]. Intramammary infection remained signifi-
cantly more often chronic if it was caused by blaZ posi-
tive (61.0% remained persistent) than blaZ negative
(25.0%) strains [34]. In Denmark, penicillin resistance in
mastitis causing S. aureus in 1950s was exclusively found
in isolates of the same phagetype and ribotype, but
found among several clones in 1992 [35]. The authors
suggested that penicillin-resistance was introduced to
bovine Staphylococcus population first by one clone but
then became widespread among several clones, probably
due to horizontal transfer. According to a Norwegian
study, 99 of 107 penicillin and tetracycline resistant
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[36]. Location of the resistance genes was not deter-
mined but the resistance was suggested to have spread
through a single clone and a resistance plasmid.
Conclusions
Presence of the blaZ gene of S. aureus was pulsotype-
linked. Six different protein signatures were found and
all except one both in Finnish and Swedish isolates. The
protein signatures were not clearly associated with cer-
tain pulsotypes. The blaZ gene was located on plasmids
in more than half of the isolates. The plasmid location of
the blaZ gene was not statistically significantly more
common in Finland than in Sweden, and hence does not
explain the higher penicillin-resistance in S. aureus caus-
ing bovine mastitis in Finland compared to Sweden.
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